Mandy Harting, MD
MOHS-Micrographic Surgery · The Woodlands, TXNPI 1437324480
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 330 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,119, 2.1 times the $998 reported in 2019.
Across 330 payments — averaging $22.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$2K
- Lilly USA, LLC$730
- Incyte Corporation$651
- Regeneron Healthcare Solutions, Inc.$608
- Sanofi$588
- plus $2K from 18 others
What the payments were for
- Food & beverage$7,472100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 80 | $1,631 |
| Johnson & Johnson | 57 | $1,554 |
| Lilly USA, LLC | 33 | $730 |
| Incyte Corporation | 29 | $651 |
| Regeneron Healthcare Solutions, Inc. | 22 | $608 |
| Sanofi | 21 | $588 |
| Novartis | 22 | $443 |
| Sun Pharmaceutical Industries Inc. | 11 | $270 |
| UCB, Inc. | 8 | $194 |
| Amgen | 9 | $166 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 10 | $165 |
| Bristol Myers Squibb | 8 | $130 |
| LEO Pharma Inc. | 4 | $74 |
| Fresenius Kabi USA, LLC | 2 | $57 |
| Galderma Laboratories, L.p. | 4 | $49 |
| Almirall LLC | 2 | $36 |
| Krystal Biotech Inc | 1 | $21 |
| Dermavant Sciences, Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Verrica Pharmaceuticals Inc. | 1 | $14 |
| Botanix SB Inc | 1 | $14 |
| Dermira, Inc. | 1 | $14 |
| Biofrontera Inc. | 1 | $9 |
How this compares
$7,472 in reported general payments places this provider in the 80th percentile of 109 mohs-micrographic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 88 | $985 |
| Cephalexin | 92 | $570 |
| Doxycycline Hyclate | 39 | $333 |
| Mupirocin | 28 | $197 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in The Woodlands
- Julie CroleyThe Woodlands$30K
- Brent ShookThe Woodlands$5K
- Nhan NguyenThe Woodlands$1K
- Aaron FarbergRockwall$1.5M
- Suneel ChilukuriBellaire$288K
- Ryan O QuinnSan Antonio$167K
- Paul FriedmanHouston$131K
- Brent SpencerFrisco$45K
- Kayla McNieceBellaire$13K
- Hubert ChodkiewiczCedar Park$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.